Cargando…
ELABELA protects against diabetic kidney disease by activating high glucose-inhibited renal tubular autophagy
ELABELA (ELA), an endogenous ligand of the apelin receptor (also known as apelin peptide jejunum [APJ]), has been shown to decrease in the plasma of patients with diabetic kidney disease (DKD). In the current study, we explored the potential function as well as the underlying mechanisms of ELA in DK...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Editorial Department of Journal of Biomedical Research
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687528/ https://www.ncbi.nlm.nih.gov/pubmed/38018421 http://dx.doi.org/10.7555/JBR.37.20220214 |